Serpin B5/Maspin Antibody [DyLight 488]
Novus Biologicals, part of Bio-Techne | Catalog # NB110-97377G
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ICC/IF (Negative), Knockdown Validated, Western Blot
Label
DyLight 488 (Excitation = 493 nm, Emission = 518 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide made to an internal portion of human MASPIN (within residues 100-200). [Swiss-Prot# P36952]
Localization
Secreted, extracellular space.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Serpin B5/Maspin Antibody [DyLight 488]
Application
Recommended Usage
ICC/IF (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Knockdown Validated
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Serpin B5/Maspin
Alternate Names
Maspin, PI5
Gene Symbol
SERPINB5
Additional Serpin B5/Maspin Products
Product Documents for Serpin B5/Maspin Antibody [DyLight 488]
Product Specific Notices for Serpin B5/Maspin Antibody [DyLight 488]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...